Kindred Biosciences, Inc.
SEC CIK 1561743 · goqxve5$ · last insider filing 2021-09-13
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Montgomery Herbert D | Director | filed 2016 - 2021 |
| Chin Richard | Director · President and CEO | filed 2013 - 2021 |
| Bevers Denise | Director · President and COO | filed 2013 - 2021 |
| Townsend Raymond | Director | filed 2013 - 2021 |
| Veszpremi Ervin | Director | filed 2013 - 2021 |
| Mccracken Joseph S | Director | filed 2018 - 2021 |
| Liu Nanxi | Director | filed 2021 - 2021 |
| Lien Lyndon | Director | filed 2021 - 2021 |
| Mario Ernest | Director | filed 2013 - 2021 |
| Nodelman Oleg | Director | filed 2013 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wee Wendy | Chief Financial Officer | filed 2017 - 2021 |
| Zhan Hangjun | Chief Scientific Officer | filed 2018 - 2021 |
| Sundlof Stephen | Senior Vice President | filed 2013 - 2017 |
| Galliker Stephen S | Chief Financial Officer | filed 2013 - 2014 |
| Hawley Selby Blake | Chief Commercial Officer | filed 2014 - 2014 |
| Schultz Kevin | Chief Scientific Officer | filed 2013 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.